The problem is that this company does not have a good history of fulfilling on its promises.
Then big test is whether the new management at IFE can actually deliver . . . and the jury is out.
- Forums
- ASX - By Stock
- IGO
- Ann: New High Grade Hematite at Twin Peaks
Featured News
Add IGO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.21 |
Change
0.010(0.19%) |
Mkt cap ! $3.945B |
Open | High | Low | Value | Volume |
$5.11 | $5.30 | $5.11 | $33.75M | 6.499M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5241 | $5.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.22 | 18702 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 5.190 |
3 | 1697 | 5.180 |
4 | 119034 | 5.170 |
3 | 18472 | 5.160 |
3 | 19979 | 5.150 |
Price($) | Vol. | No. |
---|---|---|
5.220 | 16567 | 2 |
5.230 | 18472 | 3 |
5.240 | 57781 | 2 |
5.250 | 16817 | 2 |
5.260 | 12130 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
IGO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online